BNTX
87.51+1.65 +1.92%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- BNTX
- Exchange
- NMS
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $21.7B
- Employees
- 7,807
- Currency
- USD
- Website
- https://www.biontech.de
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab…